TGFβRII, which is thought to function as a tumor suppressor in many solid tumors, where TGF-β signaling is important for inhibition of epithelial cell growth, is downregulated in NSCLC through methylation of its promoter (Zhang et al., 2004). The gene discussed is TGFB1; the disease is neoplasm.